Hec1 Antibodies

Santa Cruz Biotechnology features a diverse variety of Hec1 monoclonal antibodies for research in understanding Hec1's role in cellular processes. Hec1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Hec1, also known as Hec1/Nek2, is a crucial component involved in the regulation of the cell cycle and mitotic progression. Hec1 plays a significant role in the proper attachment of microtubules to kinetochores, ensuring accurate chromosome segregation during cell division. Research has shown that Hec1 expression levels are altered in various cancers, highlighting its importance in therapeutic research. Understanding Hec1's function is essential for developing targeted cancer treatments and improving patient outcomes. Investigating the mechanisms of Hec1 regulation provides valuable insights into cell cycle control and chromosome stability. Current research focuses on how Hec1 modifications affect cancer progression and treatment resistance. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of cancer biology and cell cycle regulation, contributing to the development of more effective therapeutic strategies.